Joshua H. Bilenker
CIK 1612312 · President & CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$53.6K
Companies
5
Total Filings
41
Lifetime Open-Market Net
-$42.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANA | Director | 20,000 | $2.68 | $53.6K | $500.0K | 9 | 2026-06-05 |
| GOSS | Director | — | $0.16 | — | $0 | 4 | 2022-07-15 |
| Loxo Oncology, Inc. (LOXO) Delisted | President & CEO | 0 | — | — | -$43.23M | 25 | 2019-02-15 |
| ViewRay, Inc. (VRAY) Delisted | Director | 7,480,887 | $0.03 | $187.0K | $0 | 1 | 2016-09-15 |
| TTOO | Director | — | $0.00 | — | $0 | 2 | 2016-06-21 |
Recent Filings · Page 2 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-05 | SANA | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2019-06-11 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2019-02-15 | Loxo Oncology, Inc. (LOXO) Delisted | Disp (D) | −192,707 | -$45.29M | EDGAR |
| 2019-01-17 | Loxo Oncology, Inc. (LOXO) Delisted | Exer (M) | +7,500 | $8.9K | EDGAR |
| 2019-01-02 | Loxo Oncology, Inc. (LOXO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-12 | Loxo Oncology, Inc. (LOXO) Delisted | Mixed | — | -$2.44M | EDGAR |
| 2018-11-28 | Loxo Oncology, Inc. (LOXO) Delisted | Mixed | +29,000 | -$2.72M | EDGAR |
| 2018-10-05 | Loxo Oncology, Inc. (LOXO) Delisted | Mixed | — | -$3.23M | EDGAR |
| 2018-09-14 | Loxo Oncology, Inc. (LOXO) Delisted | Mixed | — | -$3.29M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.